OpenURL Connection Search

Select item for more details and to access through your institution.

Farnesyl Transferase Inhibitors in Myeloid Disorders.
Published in:
Oncology (08909091), 2005, v. 19, n. 8, p. 1043
By:
- Lancet, Jeffrey E.
Publication type:
Article
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.
Published in:
Biologics: Targets & Therapy, 2008, v. 2, n. 3, p. 491
By:
- Karp, Judith E.;
- Lancet, Jeffrey E.
Publication type:
Article
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes.
Published in:
British Journal of Haematology, 2022, v. 198, n. 4, p. 713, doi. 10.1111/bjh.18319
By:
- Volpe, Virginia O.;
- Al Ali, Najla;
- Chan, Onyee;
- Padron, Eric;
- Sallman, David A.;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.
Published in:
British Journal of Haematology, 2019, v. 184, n. 3, p. 450, doi. 10.1111/bjh.15099
By:
- McGraw, Kathy L.;
- Nguyen, Johnny;
- Al Ali, Najla H.;
- Komrokji, Rami S.;
- Sallman, David;
- Zhang, Xiaohui;
- Song, Jinming;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Moscinski, Lynn C.;
- List, Alan F.;
- Zhang, Ling
Publication type:
Article
Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis.
Published in:
British Journal of Haematology, 2013, v. 163, n. 3, p. 315, doi. 10.1111/bjh.12528
By:
- Kharfan‐Dabaja, Mohamed A.;
- Hamadani, Mehdi;
- Reljic, Tea;
- Pyngolil, Rachel;
- Komrokji, Rami S.;
- Lancet, Jeffrey E.;
- Fernandez, Hugo F.;
- Djulbegovic, Benjamin;
- Kumar, Ambuj
Publication type:
Article
Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes.
Published in:
British Journal of Haematology, 2013, v. 162, n. 4, p. 517, doi. 10.1111/bjh.12436
By:
- Komrokji, Rami S.;
- Raza, Azra;
- Lancet, Jeffrey E.;
- Ren, Chen;
- Taft, David;
- Maniar, Manoj;
- Wilhelm, Francois;
- List, Alan F.
Publication type:
Article
Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia.
Published in:
American Journal of Hematology, 2023, v. 98, n. 12, p. E360, doi. 10.1002/ajh.27092
By:
- Patel, Parth C.;
- Ball, Somedeb;
- Jain, Akriti G.;
- Wang, Chen;
- Hussaini, Mohammad O.;
- Aguirre, Luis E.;
- Chan, Onyee;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Published in:
American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Aguirre, Luis E.;
- Al Ali, Najla;
- Zhang, Yumeng;
- Chan, Onyee;
- Kuykendall, Andrew T.;
- Sweet, Kendra L.;
- Lancet, Jeffrey E.;
- Swoboda, David M.;
- Padron, Eric;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Navigating the Changing Landscape in the Treatment and Management of Acute Myeloid Leukemia: Key Considerations in Managed Care Decision Making.
Published in:
Journal of Managed Care Medicine, 2023, v. 26, n. 1, p. 13
By:
- Lancet, Jeffrey E.
Publication type:
Article
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.
Published in:
Annals of Hematology, 2024, v. 103, n. 6, p. 1941, doi. 10.1007/s00277-024-05760-6
By:
- Jain, Akriti G;
- Gesiotto, Quinto;
- Ball, Somedeb;
- Nodzon, Lisa;
- Rodriguez, Amanda;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David A.;
- Lancet, Jeffrey E;
- Pinilla-Ibarz, Javier;
- Sweet, Kendra
Publication type:
Article
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.
Published in:
2018
By:
- Kuykendall, Andrew T.;
- Shah, Savan;
- Talati, Chetasi;
- Al Ali, Najla;
- Sweet, Kendra;
- Padron, Eric;
- Sallman, David A.;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Zuckerman, Kenneth S.;
- Komrokji, Rami S.
Publication type:
journal article
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.
Published in:
2018
By:
- Duong, Vu H.;
- Padron, Eric;
- Al Ali, Najla H.;
- Lancet, Jeffrey E.;
- Hall, Jeff;
- Kwok, Brian;
- Zhang, Ling;
- Epling-Burnette, Pearlie K.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.
Published in:
2014
By:
- Horna, Pedro;
- Zhang, Ling;
- Sotomayor, Eduardo M;
- Lancet, Jeffrey E;
- Moscinski, Lynn C
Publication type:
journal article
Diagnostic Immunophenotype of Acute Promyelocytic Leukemia Before and Early During Therapy With All-traits Retinoic Acid.
Published in:
American Journal of Clinical Pathology, 2014, v. 142, n. 4, p. 546, doi. 10.1309/AJCPPOKEHBP53ZHV
By:
- Horna, Pedro;
- Ling Zhang;
- Sotomayor, Eduardo M;
- Lancet, Jeffrey E.;
- Moscinski, Lynn C.
Publication type:
Article
Poor outcome of patients with myelodysplastic syndrome after azacitidine treatment failure.
Published in:
2013
By:
- Duong, Vu H;
- Lin, Karen;
- Reljic, Tea;
- Kumar, Ambuj;
- Al Ali, Najla H;
- Lancet, Jeffrey E;
- List, Alan F;
- Komrokji, Rami S
Publication type:
Journal Article
Phase II study of SU5416a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitorin patients with refractory myeloproliferative diseases.
Published in:
Cancer (0008543X), 2003, v. 97, n. 8, p. 1920
By:
- Francis J. Giles;
- Maureen A. Cooper;
- Lewis Silverman;
- Judith E. Karp;
- Jeffrey E. Lancet;
- Maurizio Zangari;
- Paul J. Shami;
- Khuda D. Khan;
- Alison L. Hannah;
- Julie M. Cherrington;
- Deborah A. Thomas;
- Guillermo Garcia-Manero;
- Maher Albitar;
- Hagop M. Kantarjian;
- Alison T. Stopeck
Publication type:
Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
By:
- Ionescu, Filip;
- David, Jerel C.;
- Ravichandran, Apoorva;
- Sallman, David A.;
- Sweet, Kendra;
- Komrokji, Rami S.;
- Chan, Onyee;
- Kuykendall, Andrew;
- Padron, Eric;
- Faramand, Rawan;
- Bejanyan, Nelli;
- Khimani, Farhad;
- Elmariah, Hany;
- Pidala, Joseph;
- Mishra, Asmita;
- Perez, Lia;
- Nishihori, Taiga;
- Lancet, Jeffrey E.
Publication type:
Article
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
By:
- Jain, Akriti G.;
- Ball, Somedeb;
- Aguirre, Luis E.;
- Tobon, Katherine A.;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David;
- Lancet, Jeffrey E.;
- Sweet, Kendra
Publication type:
Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S293, doi. 10.1016/S2152-2650(21)01700-6
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Al Ali, Najla;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Al Ali, Najla;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Poster: AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01340-9
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Ali, Najla Al;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E.;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Published in:
2021
By:
- Gesiotto, Quinto J.;
- Swoboda, David M.;
- Shallis, Rory M.;
- Al Ali, Najla;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Song, Jinming;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Zeidan, Amer M.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Published in:
2021
By:
- Schwabkey, Zaker I.;
- Al Ali, Najla;
- Chan, Onyee;
- Sallman, David A.;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
journal article
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.
Published in:
2020
By:
- Sallman, David A.;
- Barnard, John;
- Al Ali, Najla H.;
- Garcia-Manero, Guillermo;
- Sekeres, Mikkael A.;
- DeZern, Amy;
- Steensma, David P.;
- Roboz, Gail;
- Jabbour, Elias;
- Maciejewski, Jaroslaw P.;
- Pierce, Sherry;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Kantarjian, Hagop;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.
Published in:
2020
By:
- Zhang, Qing;
- Haider, Mintallah;
- Al Ali, Najla H.;
- Lancet, Jeffrey E.;
- Epling-Burnette, Pearlie K.;
- List, Alan F.;
- Padron, Eric;
- Komrokji, Rami S.
Publication type:
journal article
Debate: Should All Older AML Patients and Younger Patients with Adverse Biology Routinely Receive HMA/of 3+7/? CON.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S89, doi. 10.1016/j.clml.2019.07.431
By:
- Lancet, Jeffrey E.
Publication type:
Article
Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial.
Published in:
2019
By:
- Komrokji, Rami S.;
- Al Ali, Najla H.;
- Padron, Eric;
- Cogle, Christopher;
- Tinsley, Sara;
- Sallman, David;
- Lancet, Jeffrey E.;
- Lis, Alan F.
Publication type:
journal article
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes.
Published in:
2019
By:
- Komrokji, Rami S.;
- Wei, Sheng;
- Mailloux, Adam W.;
- Zhang, Ling;
- Padron, Eric;
- Sallman, David;
- Lancet, Jeffrey E.;
- Tinsley, Sara;
- Nardelli, Lisa A.;
- Pinilla-Ibarz, Javier;
- Epling-Burnette, Pearlie K.;
- List, Alan F.
Publication type:
journal article
When Two Roads Diverge: Genetically Inspired Prognostic Scoring System (GIPSS) Outperforms DIPSS in Myelofibrosis Patients where the Two Risk Models Widely Differ.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S266, doi. 10.1016/j.clml.2018.07.183
By:
- Kuykendall, Andrew;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami
Publication type:
Article
Outcomes in Older Patients with Newly Diagnosed, High-risk/Secondary Acute Myeloid Leukemia (sAML) Who Received Consolidation in a Phase 3 Study of CPX-351 versus Conventional 7+3/5+2 Cytarabine and Daunorubicin.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S208, doi. 10.1016/j.clml.2018.07.064
By:
- Kolitz, Jonathan;
- Strickland, Stephen A.;
- Cortes, Jorge E.;
- Hogge, Donna;
- Lancet, Jeffrey E.;
- Goldberg, Stuart;
- Ryan, Robert J.;
- Chiarella, Michael;
- Louie, Arthur C.;
- Uy, Geoffrey L.
Publication type:
Article
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.
Published in:
2017
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Al Ali, Najla;
- Sweet, Kendra;
- Padron, Eric;
- Sallman, David A.;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Zuckerman, Kenneth S.;
- Komrokji, Rami S.
Publication type:
journal article
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.
Published in:
2017
By:
- Mirza, Abu-Sayeef;
- Lancet, Jeffrey E.;
- Sweet, Kendra;
- Padron, Eric;
- Pinilla-Ibarz, Javier;
- Nardelli, Lisa;
- Cubitt, Christopher;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.
Published in:
2017
By:
- Apuri, Susmitha;
- Al Ali, Najla;
- Padron, Eric;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Published in:
2016
By:
- Ramadan, Hanadi;
- Duong, Vu H.;
- Al Ali, Najla;
- Padron, Eric;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
Published in:
Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 563, doi. 10.1002/cpt.1641
By:
- Hicks, J. Kevin;
- Quilitz, Rod E.;
- Komrokji, Rami S.;
- Kubal, Timothy E.;
- Lancet, Jeffrey E.;
- Pasikhova, Yanina;
- Qin, Dahui;
- So, Wonhee;
- Caceres, Gisela;
- Kelly, Kerry;
- Salchert, Yasmina S.;
- Shahbazian, Kevin;
- Abbas‐Aghababazadeh, Farnoosh;
- Fridley, Brooke L.;
- Velez, Ana P.;
- McLeod, Howard L.;
- Greene, John N.
Publication type:
Article
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 281, doi. 10.1007/s00280-023-04511-0
By:
- Shafer, Danielle;
- Kagan, Amanda B.;
- Rudek, Michelle A.;
- Kmieciak, Maciej;
- Tombes, Mary Beth;
- Shrader, Ellen;
- Bandyopadhyay, Dipankar;
- Hudson, Daniel;
- Sankala, Heidi;
- Weir, Caryn;
- Lancet, Jeffrey E.;
- Grant, Steven
Publication type:
Article
Persistent cytarabine and daunorubicin exposure after administration of novel liposomal formulation CPX-351: population pharmacokinetic assessment.
Published in:
2018
By:
- Nikanjam, Mina;
- Capparelli, Edmund V.;
- Lancet, Jeffrey E.;
- Louie, Arthur;
- Schiller, Gary
Publication type:
journal article
Integrative molecular subtypes of acute myeloid leukemia.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00836-4
By:
- Mo, Qianxing;
- Yun, Seongseok;
- Sallman, David A.;
- Vincelette, Nicole D.;
- Peng, Guang;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Padron, Eric
Publication type:
Article
Integrative molecular subtypes of acute myeloid leukemia.
Published in:
2023
By:
- Mo, Qianxing;
- Yun, Seongseok;
- Sallman, David A.;
- Vincelette, Nicole D.;
- Peng, Guang;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Padron, Eric
Publication type:
Letter
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00744-z
By:
- Komrokji, Rami S.;
- Singh, Avani M.;
- Ali, Najla Al;
- Chan, Onyee;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey E.;
- Sallman, David A.
Publication type:
Article
Driver mutation‐specific clinical and genomic correlates differ between primary and secondary myelofibrosis.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. E314, doi. 10.1002/ajh.25625
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Sallman, David;
- Komrokji, Rami S.
Publication type:
Article
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients.
Published in:
American Journal of Hematology, 2019, v. 94, n. 1, p. 87, doi. 10.1002/ajh.25335
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Published in:
American Journal of Hematology, 2018, v. 93, n. 2, p. E49, doi. 10.1002/ajh.24980
By:
- Walter, Roland B.;
- Michaelis, Laura C.;
- Othus, Megan;
- Uy, Geoffrey L.;
- Radich, Jerald P.;
- Little, Richard F.;
- Hita, Sandi;
- Saini, Lalit;
- Foran, James M.;
- Gerds, Aaron T.;
- Klepin, Heidi D.;
- Hay, Annette E.;
- Assouline, Sarit;
- Lancet, Jeffrey E.;
- Couban, Stephen;
- Litzow, Mark R.;
- Stone, Richard M.;
- Erba, Harry P.
Publication type:
Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Published in:
American Journal of Hematology, 2017, v. 92, n. 3, p. 232, doi. 10.1002/ajh.24627
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- Sweet, Kendra;
- Al Ali, Najla H.;
- Padron, Eric;
- Kubal, Timothy E.;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Autoimmune diseases and myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2016, v. 91, n. 5, p. E280, doi. 10.1002/ajh.24333
By:
- Komrokji, Rami S.;
- Kulasekararaj, Austin;
- Al Ali, Najla H.;
- Kordasti, Shahram;
- Bart-Smith, Emily;
- Craig, Benjamin M.;
- Padron, Eric;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Pinilla-Ibarz, Javier;
- List, Alan F.;
- Mufti, Ghulam J.;
- Epling-Burnette, Pearlie K.
Publication type:
Article
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.
Published in:
American Journal of Hematology, 2015, v. 90, n. 9, p. 796, doi. 10.1002/ajh.24087
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- De Castro, Carlos M.;
- Rizzieri, David A.;
- Melchert, Magda;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.
Published in:
American Journal of Hematology, 2015, v. 90, n. 7, p. 602, doi. 10.1002/ajh.24014
By:
- Brayer, Jason;
- Lancet, Jeffrey E.;
- Powers, John;
- List, Alan;
- Balducci, Lodovico;
- Komrokji, Rami;
- Pinilla-Ibarz, Javier
Publication type:
Article
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2014, v. 89, n. 8, p. 809, doi. 10.1002/ajh.23749
By:
- Komrokji, Rami S.;
- Padron, Eric;
- Yu, Daohai;
- Fulp, William J.;
- Rodriguez, Yuraima;
- Tinsley, Sara;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article

Found: 63